Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1993 May;61(5):1779–1785. doi: 10.1128/iai.61.5.1779-1785.1993

Increased C3 production in human monocytes after stimulation with Candida albicans is suppressed by granulocyte-macrophage colony-stimulating factor.

A K Høgåsen 1, T G Abrahamsen 1
PMCID: PMC280765  PMID: 8478067

Abstract

Activation of the complement system is an important part of host resistance against fungal infections. When human monocytes, cultured for 2 days or more, were treated in vitro with Candida albicans for 24 h, an enhancement of their biosynthesis of the complement components C3 and factor B was found. However, when C. albicans was administered to freshly isolated monocytes, a consistent stimulation of factor B biosynthesis occurred, while the C3 production was increased in about 50% of the donors. C. albicans also induced the release of granulocyte-macrophage colony-stimulating factor (GM-CSF) from the cultured cells, apparently in larger amounts in the donors in whom no stimulation of C3 production was found. An antibody to GM-CSF administered with the yeast at the initiation of the monocyte culture caused an increase in the C3 production. Furthermore, when monocytes were treated with recombinant human GM-CSF either at the same time as or 4 days prior to the addition of C. albicans, the increase in C3 production was suppressed or neutralized, while factor B biosynthesis was unaffected. Taken together, these results indicate that monocytes respond to C. albicans with an increased production of complement factors. This may be an important mechanism both for opsonization of the fungus and for initiation of an inflammatory reaction. At an inflammatory site, this complement response may be suppressed by locally produced GM-CSF.

Full text

PDF
1779

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barcinski M. A., Schechtman D., Quintao L. G., Costa D. de A., Soares L. R., Moreira M. E., Charlab R. Granulocyte-macrophage colony-stimulating factor increases the infectivity of Leishmania amazonensis by protecting promastigotes from heat-induced death. Infect Immun. 1992 Sep;60(9):3523–3527. doi: 10.1128/iai.60.9.3523-3527.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bensa J. C., Reboul A., Colomb M. G. Biosynthesis in vitro of complement subcomponents C1q, C1s and C1 inhibitor by resting and stimulated human monocytes. Biochem J. 1983 Nov 15;216(2):385–392. doi: 10.1042/bj2160385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Blanchard D. K., Michelini-Norris M. B., Djeu J. Y. Production of granulocyte-macrophage colony-stimulating factor by large granular lymphocytes stimulated with Candida albicans: role in activation of human neutrophil function. Blood. 1991 May 15;77(10):2259–2265. [PubMed] [Google Scholar]
  4. Blanchard D. K., Michelini-Norris M. B., Pearson C. A., McMillen S., Djeu J. Y. Production of granulocyte-macrophage colony-stimulating factor (GM-CSF) by monocytes and large granular lymphocytes stimulated with Mycobacterium avium-M. intracellulare: activation of bactericidal activity by GM-CSF. Infect Immun. 1991 Jul;59(7):2396–2402. doi: 10.1128/iai.59.7.2396-2402.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cole F. S., Schneeberger E. E., Lichtenberg N. A., Colten H. R. Complement biosynthesis in human breast-milk macrophages and blood monocytes. Immunology. 1982 Jun;46(2):429–441. [PMC free article] [PubMed] [Google Scholar]
  6. Cooper P. H., Mayer P., Baggiolini M. Stimulation of phagocytosis in bone marrow-derived mouse macrophages by bacterial lipopolysaccharide: correlation with biochemical and functional parameters. J Immunol. 1984 Aug;133(2):913–922. [PubMed] [Google Scholar]
  7. Corradin S. B., Mauël J. Phagocytosis of Leishmania enhances macrophage activation by IFN-gamma and lipopolysaccharide. J Immunol. 1991 Jan 1;146(1):279–285. [PubMed] [Google Scholar]
  8. Djeu J. Y., Blanchard D. K. Regulation of human polymorphonuclear neutrophil (PMN) activity against Candida albicans by large granular lymphocytes via release of a PMN-activating factor. J Immunol. 1987 Oct 15;139(8):2761–2767. [PubMed] [Google Scholar]
  9. Djeu J. Y., Blanchard D. K., Richards A. L., Friedman H. Tumor necrosis factor induction by Candida albicans from human natural killer cells and monocytes. J Immunol. 1988 Dec 1;141(11):4047–4052. [PubMed] [Google Scholar]
  10. Eischen A., Vincent F., Bergerat J. P., Louis B., Faradji A., Bohbot A., Oberling F. Long term cultures of human monocytes in vitro. Impact of GM-CSF on survival and differentiation. J Immunol Methods. 1991 Oct 25;143(2):209–221. doi: 10.1016/0022-1759(91)90046-i. [DOI] [PubMed] [Google Scholar]
  11. Ezekowitz R. A., Sim R. B., Hill M., Gordon S. Local opsonization by secreted macrophage complement components. Role of receptors for complement in uptake of zymosan. J Exp Med. 1984 Jan 1;159(1):244–260. doi: 10.1084/jem.159.1.244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fearon D. T., Wong W. W. Complement ligand-receptor interactions that mediate biological responses. Annu Rev Immunol. 1983;1:243–271. doi: 10.1146/annurev.iy.01.040183.001331. [DOI] [PubMed] [Google Scholar]
  13. Gemsa D., Seitz M., Menzel J., Grimm W., Kramer W., Till G. Modulation of phagocytosis induced prostaglandin release from macrophages. Adv Exp Med Biol. 1979;114:421–426. doi: 10.1007/978-1-4615-9101-6_69. [DOI] [PubMed] [Google Scholar]
  14. Gilmore B. J., Retsinas E. M., Lorenz J. S., Hostetter M. K. An iC3b receptor on Candida albicans: structure, function, and correlates for pathogenicity. J Infect Dis. 1988 Jan;157(1):38–46. doi: 10.1093/infdis/157.1.38. [DOI] [PubMed] [Google Scholar]
  15. Goodrum K. J. Stimulation of complement component C3 synthesis in macrophagelike cell lines by group B streptococci. Infect Immun. 1987 May;55(5):1101–1105. doi: 10.1128/iai.55.5.1101-1105.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Haeffner-Cavaillon N., Cavaillon J. M., Laude M., Kazatchkine M. D. C3a(C3adesArg) induces production and release of interleukin 1 by cultured human monocytes. J Immunol. 1987 Aug 1;139(3):794–799. [PubMed] [Google Scholar]
  17. Hamilton A. O., Jones L., Morrison L., Whaley K. Modulation of monocyte complement synthesis by interferons. Biochem J. 1987 Mar 15;242(3):809–815. doi: 10.1042/bj2420809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hartung H. P., Hadding U. Synthesis of complement by macrophages and modulation of their functions through complement activation. Springer Semin Immunopathol. 1983;6(4):283–326. doi: 10.1007/BF02116277. [DOI] [PubMed] [Google Scholar]
  19. Hetland G., Johnson E., Falk R. J., Eskeland T. Synthesis of complement components C5, C6, C7, C8 and C9 in vitro by human monocytes and assembly of the terminal complement complex. Scand J Immunol. 1986 Oct;24(4):421–428. doi: 10.1111/j.1365-3083.1986.tb02130.x. [DOI] [PubMed] [Google Scholar]
  20. Johnson E., Hetland G. Mononuclear phagocytes have the potential to synthesize the complete functional complement system. Scand J Immunol. 1988 May;27(5):489–493. doi: 10.1111/j.1365-3083.1988.tb02375.x. [DOI] [PubMed] [Google Scholar]
  21. Kaplan G., Gaudernack G. In vitro differentiation of human monocytes. Differences in monocyte phenotypes induced by cultivation on glass or on collagen. J Exp Med. 1982 Oct 1;156(4):1101–1114. doi: 10.1084/jem.156.4.1101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kozel T. R., Brown R. R., Pfrommer G. S. Activation and binding of C3 by Candida albicans. Infect Immun. 1987 Aug;55(8):1890–1894. doi: 10.1128/iai.55.8.1890-1894.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lappin D., Hamilton A. D., Morrison L., Aref M., Whaley K. Synthesis of complement components (C3, C2, B and C1-inhibitor) and lysozyme by human monocytes and macrophages. J Clin Lab Immunol. 1986 Jul;20(3):101–105. [PubMed] [Google Scholar]
  24. Lee M. T., Kaushansky K., Ralph P., Ladner M. B. Differential expression of M-CSF, G-CSF, and GM-CSF by human monocytes. J Leukoc Biol. 1990 Mar;47(3):275–282. doi: 10.1002/jlb.47.3.275. [DOI] [PubMed] [Google Scholar]
  25. McPhaden A., Lappin D., Whaley K. Enhancement of monocyte complement component synthesis by antigen--antibody complexes. Immunology. 1981 Sep;44(1):193–200. [PMC free article] [PubMed] [Google Scholar]
  26. Metcalf D. The colony stimulating factors. Discovery, development, and clinical applications. Cancer. 1990 May 15;65(10):2185–2195. doi: 10.1002/1097-0142(19900515)65:10<2185::aid-cncr2820651005>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  27. Miyama A., Kawamoto Y., Ichikawa H., Moriyama T., Okamoto K., Takahashi T. Complement proteins and macrophages. III. The production of factor B by particle-ingesting macrophages. Microbiol Immunol. 1981;25(2):195–203. doi: 10.1111/j.1348-0421.1981.tb00022.x. [DOI] [PubMed] [Google Scholar]
  28. Morrison L., Whaley K. Phagocytosis inhibits the production of C2 by human monocytes. Int Arch Allergy Appl Immunol. 1983;71(3):271–275. doi: 10.1159/000233402. [DOI] [PubMed] [Google Scholar]
  29. Morstyn G., Burgess A. W. Hemopoietic growth factors: a review. Cancer Res. 1988 Oct 15;48(20):5624–5637. [PubMed] [Google Scholar]
  30. Pereira H. A., Hosking C. S. The role of complement and antibody in opsonization and intracellular killing of Candida albicans. Clin Exp Immunol. 1984 Aug;57(2):307–314. [PMC free article] [PubMed] [Google Scholar]
  31. Riklis I., Kletter Y., Bleiberg I., Fabian I. Biological properties in vitro of a combination of recombinant murine interleukin-3 and granulocyte-macrophage colony-stimulating factor. Eur J Haematol. 1989 Apr;42(4):375–381. doi: 10.1111/j.1600-0609.1989.tb01228.x. [DOI] [PubMed] [Google Scholar]
  32. Robin G., Markovich S., Athamna A., Keisari Y. Human recombinant granulocyte-macrophage colony-stimulating factor augments viability and cytotoxic activities of human monocyte-derived macrophages in long-term cultures. Lymphokine Cytokine Res. 1991 Aug;10(4):257–263. [PubMed] [Google Scholar]
  33. Sasada M., Johnston R. B., Jr Macrophage microbicidal activity. Correlation between phagocytosis-associated oxidative metabolism and the killing of Candida by macrophages. J Exp Med. 1980 Jul 1;152(1):85–98. doi: 10.1084/jem.152.1.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Smith P. D., Lamerson C. L., Banks S. M., Saini S. S., Wahl L. M., Calderone R. A., Wahl S. M. Granulocyte-macrophage colony-stimulating factor augments human monocyte fungicidal activity for Candida albicans. J Infect Dis. 1990 May;161(5):999–1005. doi: 10.1093/infdis/161.5.999. [DOI] [PubMed] [Google Scholar]
  35. Strunk R. C., Whitehead A. S., Cole F. S. Pretranslational regulation of the synthesis of the third component of complement in human mononuclear phagocytes by the lipid A portion of lipopolysaccharide. J Clin Invest. 1985 Sep;76(3):985–990. doi: 10.1172/JCI112099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Sutton M. B., Strunk R. C., Cole F. S. Regulation of the synthesis of the third component of complement and factor B in cord blood monocytes by lipopolysaccharide. J Immunol. 1986 Feb 15;136(4):1366–1372. [PubMed] [Google Scholar]
  37. Wang M., Friedman H., Djeu J. Y. Enhancement of human monocyte function against Candida albicans by the colony-stimulating factors (CSF): IL-3, granulocyte-macrophage-CSF, and macrophage-CSF. J Immunol. 1989 Jul 15;143(2):671–677. [PubMed] [Google Scholar]
  38. Whaley K. Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes. J Exp Med. 1980 Mar 1;151(3):501–516. doi: 10.1084/jem.151.3.501. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES